Enimmune (ROCO:6564) Beginning Cash Position : NT$507.55 Mil (As of Dec. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Enimmune Beginning Cash Position?

Enimmune's Beginning Cash Position for the quarter that ended in Dec. 2024 was NT$507.55 Mil.

Enimmune's quarterly Beginning Cash Position increased from Dec. 2023 (NT$346.19 Mil) to Jun. 2024 (NT$359.89 Mil) and increased from Jun. 2024 (NT$359.89 Mil) to Dec. 2024 (NT$507.55 Mil).

Enimmune's annual Beginning Cash Position increased from Dec. 2022 (NT$118.39 Mil) to Dec. 2023 (NT$394.17 Mil) but then declined from Dec. 2023 (NT$394.17 Mil) to Dec. 2024 (NT$359.89 Mil).

Enimmune Beginning Cash Position Historical Data

The historical data trend for Enimmune's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Enimmune Beginning Cash Position Chart

Enimmune Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Beginning Cash Position

Get a 7-Day Free Trial

122.37

103.77

118.39

394.17

359.89

Enimmune Semi-Annual Data
	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Beginning Cash Position	Get a 7-Day Free Trial												330.32	394.17	346.19	359.89	507.55

Enimmune Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Enimmune Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Enimmune's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Enimmune Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Enimmune Corp (ROCO:6564) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

Dunhua South Road, 18th Floor-2, No. 76, Section 2, Da’an District, Taipei, TWN, 10683

Website

http://www.enimmune.com.tw

Enimmune Corp is primarily engaged in the research and development and trading of vaccines, testing reagents and biotechnology services, etc., as well as trading of related western medicines.

Enimmune Headlines

No Headlines